Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a Cash Flow Reinvestment Rate of 0.29x as of June 2023, reinvesting €601.56 Million (capex €524.46 Million plus investments €77.10 Million) from operating cash flow of €2.10 Billion. See Guangzhou Baiyunshan Pharmaceutical Hold free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited across 12 annual periods. For the full cash flow conversion analysis, see Guangzhou Baiyunshan Pharmaceutical Hold (GU5) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2024)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited. See Guangzhou Baiyunshan Pharmaceutical Hold leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.73x | €5.96 Billion | €3.44 Billion | €1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | €4.74 Billion | €4.10 Billion | €1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | €7.62 Billion | €7.00 Billion | €1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | €1.30 Billion | €5.67 Billion | €1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | €1.39 Billion | €585.19 Million | €876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | €3.63 Billion | €5.02 Billion | €2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | €909.71 Million | €5.22 Billion | €478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | €2.57 Billion | €1.83 Billion | €196.77 Million | ▲ +646.4% |
| 2016 | 0.19x | €477.18 Million | €2.54 Billion | €228.03 Million | ▼ -54.5% |
| 2015 | 0.41x | €800.01 Million | €1.94 Billion | €515.34 Million | ▲ +12.3% |
| 2014 | 0.37x | €641.36 Million | €1.75 Billion | €356.70 Million | ▲ +38.3% |
| 2013 | 0.27x | €354.40 Million | €1.34 Billion | €350.35 Million | — |